Allworth Financial LP lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2,117.4% during ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

Spotlight Therapeutics, a Bay Area biotech company that raised $66 million from investors, including GV, has shut down.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Iovance Biotherapeutics (IOVA – Research ...

There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...

Explore the future of organ transplants and how biotech innovations like 3D bioprinting and stem cells can solve the organ ...

In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...

In my work as a cancer researcher, I study the underlying mechanisms of how tumors develop and resist treatment. By ...